Back to Journals » OncoTargets and Therapy » Volume 6

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Total article views   HTML views PDF downloads Totals
19,341 Dovepress* 12,155+ 2,119 14,274
PubMed Central* 7,186 1,524 8,710
Totals 19,341 3,643 22,984
*Since 14 February 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
26 1 0 0 3 22

View citations on PubMed Central and Google Scholar